Nurix stock price target lowered to $12 by Leerink Partners
NegativeFinancial Markets

Nurix's stock price target has been lowered to $12 by Leerink Partners, indicating a challenging outlook for the company. This adjustment reflects concerns about Nurix's performance and market position, which could impact investor confidence and the company's future growth prospects.
— Curated by the World Pulse Now AI Editorial System